• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

21基因低复发风险评分与早期乳腺癌远处转移的相关性研究

Relationship between low recurrence risk score of 21 gene and distant metastasis of early breast cancer

摘要:

目的 探讨乳腺癌21基因低复发风险评分的激素受体阳性、人表皮生长因子受体-2(HER-2)阴性及淋巴结阴性早期乳腺癌患者发生远处转移的相关预后影响因素.方法 回顾性分析2014年5月至2018年2月河南省人民医院收治的乳腺癌21基因低复发风险评分的140例激素受体阳性、HER-2阴性及淋巴结阴性早期乳腺癌患者的临床病理资料.根据乳腺癌21基因检测复发风险值(RS)分值将患者为两组:RS 0~10分组,共74例(52.9%);RS 11~18分组,共66例(47.1%).比较两组患者肿瘤大小、肿瘤病理分级、Ki-67指数、淋巴血管侵犯等临床病理特征,治疗及远处转移预后情况.结果 RS 0~10组和RS 11~18组患者中位随访时间分别为36、39个月,共5例患者发生远处转移(RS 0~10组1例,RS 11~18组4例).两组患者整体远处转移率为3.6%,两组中在<40岁时诊断为乳腺癌的患者远处转移发生率较≥40岁时诊断为乳腺癌的患者远处转移发生率高,其中<40岁患者远处转移率为2.1%,≥40岁患者远处转移率为1.4%.结论 21基因低复发风险评分的激素受体阳性、HER-2阴性、淋巴结阴性早期乳腺癌患者术后发生远处转移率低,发病年龄<40岁可能是影响其发生远处转移的重要因素.

更多
abstracts:

Objective To investigate the prognostic factors associated with distant metastasis in early breast cancer patients with low recurrence risk score of breast cancer 21 gene detection, hormone receptor positive, HER-2 negative and lymph node negative. Methods The clinical and pathological data of 140 patients with hormone receptor-positive, HER-2-negative and lymph node-negative early breast cancer treated in Henan People's Hospital from May 2014 to February 2018 were retrospectively analyzed. According to recurrence score ( RS) score, the patients were divided into two groups, 74 cases (52. 9%) in RS 0 - 10 group and 66 cases ( 47. 1%) in RS 11 - 18 group. The clinical and pathological characteristics, treatment and prognosis of distant metastasis, such as tumor size, pathological grade, Ki-67 index and lymphatic vascular invasion were compared between the two groups. Results The median follow-up time of RS 0 -10 group and RS 11 -18 group was 36 months and 39 months, respectively. There were 5 patients with distant metastasis ( 1 case in RS 0 -10 group and 4 cases in RS 11 -18 group ) . The overall distant metastasis rate of the two groups was 3. 6%. The incidence of distant metastasis in breast cancer patients diagnosed at < 40 years old was higher than that in breast cancer patients diagnosed at≥40 years old. The distant metastasis rate of patients diagnosed aged < 40 years old was 2. 1%, and that of patients diagnosed aged ≥ 40 years old was 1. 4%. Conclusions Hormone receptor-positive, HER-2-negative and lymph node-negative early breast cancer patients with low recurrence risk score of 21 gene have a low rate of distant metastasis after operation. Diagnosed age < 40 may be an important factor affecting distant metastasis.

More
作者: 陈海军 [1] 翟保平 [1] 贾琳娇 [1] 陈涛 [1] 刘高秀 [1] 密雪芳 [1] 褚闻聆 [1] 李文涛 [1]
栏目名称: 论著
DOI: 10.3760/cma.j.issn.1674-4756.2019.06.002
发布时间: 2019-06-13
基金项目:
河南省医学科技攻关计划项目省部共建项目(201601013)Henan Medical Science and Technology Key Points Project
  • 浏览:139
  • 下载:172

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷